T1D Exchange Joins Leading Diabetes Organizations and Issues Consensus Statement

T1D Exchange Joins Leading Diabetes Organizations and Issues Consensus Statement

Leading Diabetes Organizations Issue Consensus Statement Defining Health Outcomes beyond HbA1c

The Type 1 Diabetes Outcomes Program, organized by JDRF, has identified and defined clinically meaningful T1D outcomes other than the standard measure of HbA1c.

A committee representing leading U.S. diabetes clinical and research organizations has issued a consensus statement that identifies and defines clinically meaningful type 1 diabetes (T1D) outcomes beyond hemoglobin HbA1c (A1c).

Read the Consensus Statement

2017-11-22T12:12:38+00:00 November 22nd, 2017|News|